Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study.
Domenico D'Arca , Maurizio Brausi , Maurizio Scaltriti , Serenella Astancolle
Cancer Research 63 ( 13) 3469 -3472
27
2003
Un nuovo autunno caldo nel Mezzogiorno? Note in margine al dibattito sui differenziali salariali territoriali
Maurizio Scaltriti , Giovanni Solinas , Roberta Zoboli , Andrea Ginzburg
Politica economica 14 ( 3) 377 -410
16
1998
NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, PreventsPI3K Signaling and Inhibitsthe Growth of Cancer Cellswith Activating PI3K Mutations
Violeta Serra , Ben Markman , Maurizio Scaltriti , Pieter JA Eichhorn
908
2008
Lapatinib induces HER2 stabilization and enhances the antitumor activity of trastuzumab in vivo
Santiago Ramon y Cajal , Maurizio Scaltriti , Stefania Landolfi , Chandra Verma
Cancer Research 68 2559 -2559
2008
89Zr-Trastuzumab PET/CT for Prediction of Response to HER2-targeted therapy in Patients with HER2 Mutant Lung Cancer: An Exploratory Phase 2 Trial
Mark Kris , Maurizio Scaltriti , Serge Lyashchenko , Gary Ulaner
The Journal of Nuclear Medicine 60 144 -144
4
2019
Targeted drug delivery strategies for precision medicines
Maurizio Scaltriti , Maurizio Scaltriti , Neal Rosen , Neal Rosen
Nature Reviews Materials 6 ( 4) 1 -20
199
2021
Molecular mechanisms of assembly and TRIP13-mediated remodeling of the human Shieldin complex
Maurizio Scaltriti , Guotai Xu , M. Jason de la Cruz , Juncheng Wang
Proceedings of the National Academy of Sciences of the United States of America 118 ( 8)
2
2021
Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors.
Maurizio Scaltriti , Maurizio Scaltriti , Anthony C. Faber , Bin Hu
Cell Death and Disease 12 ( 2) 1 -13
2021
Abstract PS18-13: Men1611 is a pi3k α/β selective and δ sparing inhibitor with long-lasting antitumor activity in different genetic backgrounds of pik3ca mutant breast cancer models
Stefania Capano , Mario Bigioni , Maurizio Scaltriti , Monica Binaschi
Cancer Research 81
2021
Abstract OT-17-01: Solti-1903 hope: Real-world clinical practice study to assess the impact of using comprehensive genomic data on the next treatment decision making-choice in patients with locally advanced or metastatic breast cancer in Spain
Ana Vivancos , Eva Ciruelos , Maurizio Scaltriti , Cristina Saura
Cancer Research
2021
Genomic Alterations in PIK3CA-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors.
Maurizio Scaltriti , Jorge S. Reis-Filho , Pau Castel , Sarat Chandarlapaty
Cancer Research 81 ( 9) 2470 -2480
2021
How a new drug is born.
Maurizio Scaltriti , Andrea Caporali , Steven Fawell
European Heart Journal
2021
Characterization of Ntrk fusions and Therapeutic Response to Ntrk Inhibition in Hematologic Malignancies
Maurizio Scaltriti , Omar Abdel-Wahab , Young Rock Chung , Akihide Yoshimi
Blood 130 794 -794
3
2017
José Manuel Baselga (1959-2021).
Maurizio Scaltriti
Science 372 ( 6540) 350 -350
2021
José Baselga (1959-2021).
Maurizio Scaltriti , Pau Castel , Neil Vasan , Emiliano Cocco
Cancer Cell 39 ( 5) 581 -582
2021
Abstract IA22: Studying drug resistance through PDX models
Maurizio Scaltriti
Clinical Cancer Research 22
2016
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.
Neil Vasan , Pedram Razavi , Jared L. Johnson , Hong Shao
Science 366 ( 6466) 714 -723
161
2019
Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression.
Saverio Bettuzzi , Francesca Scorcioni , Serenella Astancolle , Pierpaola Davalli
Oncogene 21 ( 27) 4328 -4334
76
2002
AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Sarat Chandarlapaty , Ayana Sawai , Maurizio Scaltriti , Vanessa Rodrik-Outmezguine
Cancer Cell 19 ( 1) 58 -71
1,015
2011
Abstract P3-03-01: Double PIK3CA mutations in cis drive oncogene addiction and enhance sensitivity to PI3K alpha inhibitors in breast cancer
Neil Vasan , Pedram Razavi , Jared L Johnson , Hong Shao
Cancer Research 80
2020
Violeta Serra, PhD Neal Rosen Saverio Bettuzzi Pau Castel Pedram Razavi Moshe Elkabets Paolo Nuciforo David M Hyman Pieter Eichhorn David Solit Maura Dickler Chandra Verma Federico Rojo Celina Garcia-Garcia Yosi Shamay Charles Rudin Filippo Montemurro Christina Leslie Poulikos I. Poulikakos Michael F Berger